Table 3.
Comparisons on immunohistochemistry between CNB and excisional biopsy (cases/total number = %).
ER proportion | ER magnitude | PR proportion | PR magnitude | HER-2 magnitude | Ki-67 proportion | |
Upward | 22/40 = 55 | 16/40 = 40 | 22/40 = 55 | 14/40 = 35 | 10/41 = 24.39 | 14/41 = 34.15 |
Downward | 5/40 = 12.50 | 5/40 = 12.50 | 7/40 = 17.50 | 8/40 = 20 | 14/41 = 34.15 | 15/41 = 36.59 |
General alteration | (22 + 5)/40 = 67.5 | (16 + 5)/40 = 52.5 | (22 + 7)/40 = 72.5 | (14 + 8)/40 = 55 | (10 + 14)/41 = 58.54 | (14 + 15)/41 = 70.73 |
Equivalent | 13/40 = 32.50 | 19/40 = 47.50 | 11/40 = 27.50 | 18/40 = 45 | 17/41 = 41.46 | 12/41 = 29.27 |
CNB = core needle biopsy, ER = estrogen receptor, HER-2 = human epidermal receptor protein-2, Ki-67 = cell proliferation antigen Ki-67, PR = progesterone receptor.